Gyno & Obs HX
Gyno & Obs HX
Gyno & Obs HX
Medical Student
Manual
Contact Information
Martin Olsen, MD
Bldg 1, VA, 3rd Floor, Rm 315B
Ob-Gyn Chairman
Bruce Selman, MD
345 N. State of Franklin, ETSU
MS3 Ob-Gyn Clerkship Director
Stephanie Nave
Bldg 1, VA, 3rd Floor, Rm 311
MS3 Ob-Gyn Clerkship Coordinator
Academic Staff:
Arlene Bennett
Bldg 1, VA, 3rd Floor, Rm 315A
Administrative Assistant
Debbie Berry
Bldg 1, VA, 3rd Floor, Rm 315
Secretary
Patti Davidson
Bldg 1, VA, 3rd Floor, Rm 315C
Residency Coordinator
Norma Long
Bldg 1, VA, 3rd Floor, Rm 314
Grand Rounds Coordinator
Linda Lyons
Bldg 1, VA, 3rd Floor
Secretary
Beth Ann Henley, Office Manager 325 N. State of Franklin
ETSU Ob-Gyn Physicians and Assoc iates
439-8097
439-7232
439-6335
439-8097
439-8755
439-6262
439-8094
439-6722
439-7272
OB/GYN Faculty:
Martin Olsen, MD, Chairman, Residency Director, Pediatric and Adolescent Gyn
Norman Assad, MD, General GYN and Reproductive Endocrinology
Kevin Breuel, PhD, Research, East TN Reproductive Endo Lab
Jessica DeMay, MD, Maternal-Fetal Medicine
Janet Drake, MD, Gynecologic Oncology, Associate Program Director
Maurice Eggleston, MD, Maternal Fetal Medicine
Anne Gebka, MD, General OB/GYN
Sherri Holmes, MD, General OB/GYN
Frederick Jelovsek, MD, Urogynecology
Uchenna Nwosu, MD, Maternal Fetal Medicine
Gary Randall, Ph,D., Embryologist
Bruce Selman, MD, PhD, General OB/GYN, Clerkship Director
Other Numbers
L&D Triage
Same Day Surgery
Same Day Holding
Main OR
Main OR Holding
ER
Fast-track
Johnson City Specialty Hospital
Dr. Thomas Jernigan, 1st Choice Ob-Gyn
431-6436
431-2050
431-2000
431-1410
431-6592
431-6561
431-5888
926-1111
431-3812
Contents
Introduction to the Department............................................................... 5
Obstetrics
Obstetrics History and Physical ................................................... 16
Intrapartum.................................................................................... 18
Delivery......................................................................................... 18
Postpartum .................................................................................... 19
Discharge....................................................................................... 21
Triage ............................................................................................ 23
Patient Calls .................................................................................. 25
OB Clinic ...................................................................................... 27
Sample Forms ............................................................................... 28
Obstetrical Pearls .......................................................................... 32
Gynecology
The Complete Gynecological History ......................................... 43
Notes for Gynecology/Gyn-Oncology......................................... 46
Gynecology Clinic ........................................................................ 48
Gynecologic Differentials ............................................................ 50
Gyn-Oncology
Gyn-Onc Sample H&P ................................................................. 52
Cancer Staging .............................................................................. 53
Sample Forms ............................................................................... 58
Common OB/Gyn Abbreviations ......................................................... 63
Recommended Resources ..................................................................... 66
Important Topics ................................................................................... 66
Notes...................................................................................................... 67
the
APGO
web
page:
Holidays
Students will follow the OB/Gyn and Gyn/Onc clinic schedules.
Professional Conduct
Student are expected to conduct themselves in a professional
manner at all times.
Appearance must be neat, clean, and professional. A clean white
coat and shirt, slacks, blouse, skirt, dress, etc. are acceptable. Scrubs
8
should not be worn in clinics and office settings and men are
expected to wear neckties during all clinics. Unless it is an
emergency, ALL staff should change into hospital provided scrubs
immediately prior to entering operating rooms. OSHA rules and
regulations are mandatory. Failure to comply may be reason for
dismissal. Scrubs should not be worn out of the operating or delivery
area unless appropriately covered by a clean white coat.
JCMC Identification: Nametags are required for proper dress
code for students doing clinical work at JCMC and clinic. Always
introduce yourself by name and status to staff members, nursing
personnel, patients and paramedical personnel.
Patient Responsibilities
When a patient is admitted to our service, you are required to
obtain a history and perform a physical examination. Your written
admission note must be reviewed with your attending/resident and
will be evaluated. You should include with this note a differential
diagnosis, and your plan of management. Your attending/resident will
determine to what extent you may write orders, progress notes, etc.
on the chart. It is important to request permission of the patient and
attending regarding your involvement in specific patient care. And
remember ALL patient information is to be kept confidential, and
failure to do so constitutes invasion of privacy and is
UNACCEPTABLE.
Please remember you are the medical schools ambassadors. What
you do- and the impression you create - will have a lasting effect on
the quality of medical education that will be available for those that
follow.
Patient Assignments
A list of patients admitted to ETSU Ob-Gyn will be available via
the hospital computer system. A daily list can be obtained from the
9
10
Gynecology
On the GYN unit, patient care, operating room attendance, and
admissions are required activities. You will spend part of your day in
the operating room and part in the clinic.
A number of Obstetricians and Gynecologists are using the
Ambulatory Surgical Treatment Center (ASTC or Day Surgery)
located in the professional building adjacent to JCMC. You are
encouraged to attend the cases also.
Gynecologic Oncology
1. Round on patients before residents each morning (KNOW
PATIENTS WELL).
2. Be present at all surgeries, regardless of whether or not scrubbed.
3. Round on patients on weekends.
4. Round before lectures on Wednesday, then check in with Dr.
Drake and/or residents after lectures are over.
11
Grading
Students will be evaluated by the university faculty as well as by
the clinical attendings. Frequent discussions between the faculty
members and the clinical faculty will take place during your stay with
us, and as a result your progress during this time will be continually
under surveillance.
You will be evaluated weekly by the faculty during the rotation.
These evaluations will be a combination of narrative and numerical
assessment.
The following major areas of assessment have been agreed upon in
the clinical specialties:
Fund of Knowledge of both General Medicine and Ob-Gyn.
This is the basic store of factual knowledge that the student has at
his/her disposal, and should be a reflection of information gathered in
conferences, seminars, readings, and from data gathered directly
through patient care. The manner of measurement may include
written or oral examination in the clerkship setting. This will also be
assessed in the clinical setting by your attending.
Medical Skills. This reflects the ability to obtain a history, perform
a physical examination and record these in a logical, concise manner.
Included here is the ability to perform various motor skills relevant to
our specialty. This area may be evaluated by direct observation or
evaluation of the written comments of attendings.
Problem-solving and Clinical Judgment. This is the ability to
use the information and skills from 1 and 2 (above) to solve clinical
problems in a logical fashion. The differential diagnoses at the end of
your workups will be examined to aid in the evaluation of this
category. For example, a previously healthy patient admitted at 34
weeks gestation for painless vaginal bleeding, with a transverse lie is
more likely to be a placenta previa than Von Willebrands disease,
and this should be reflected in your approach to the patient.
12
Examinations
In-Course Exams
There will be one written and one oral exam. These two
examinations serve multiple purposes. Their prime purpose is to help
train you for your National Board Exam. Though none of the
questions are in any way derived from the exam, the material covered
is representative. The oral exam will be administered by Dr. Selman
in a small group setting. The written exam will cover both OB and
GYN and students will be broken into groups and will take exam at
different times during the rotation.
Additional Evaluation
Evaluation of students will be sought from patients and hospital
personnel (other physicians and nursing personnel), as well as from
your peers. The intention here is to seek out those students who are
exemplary, and reward them for their achievements also, to identify
those who need additional help before it is too late.
Midrotation Evaluations
Each student will meet individually with Dr. Selman toward the
middle of the rotation for a preliminary subjective evaluation. This
will serve several purposes, but again mainly to identify those who
need additional help before it is too late.
Final Grade
Your final grade is calculated as follows:
13
15%
15%
35%
30%
5%
100%
Grade Scale
A
92-100
B
80-91
C
79-70
D
69-60
F
59 or below
NOTE: The faculty reserves the right to assign a failing grade (D or
F), or to require the student to remediate a portion of the course as a
precondition to being assigned his/her earned grade (I submitted)
should performance be inadequate in ANY portion of the course.
both too late for you to improve your experience with us, and for the
faculty member to deal with what may perhaps have been just a
misunderstanding.
It is extremely distressing to those of us who are particularly
interested in providing you with a quality experience when we
discover, after you have left our rotation, that a problem had existed
for which an easy correction was available but not applied because
the situation was not recognized.
Call Room
The Ob-Gyn student call room is located at the end of the long hall
of Labor and Delivery admissions. During orientation you will be
given a tour of the call rooms, the entrance code, and be assigned a
student locker.
15
Obstetrics
Obstetric Admission History and
Physical
Date __________ Time _________ Attending _________________
ID: Age, G___ P ___, LMP ______, @ ________ weeks gestation
(?consensus with EDC)
EDC ____ weeks by dates
EDC ____ weeks by ultrasound
C C : [e.g. contractions, leaking fluid, vaginal bleeding, fetal
movement, ruptured membranes, complications of pregnancy,
etc.]
Present pregnancy: Prenatal Care provided by whom? List any
complications of present pregnancy [Antenatal course
complicated by ]
PMH: Illnesses [e.g. HTN, DM, thyroid disease, asthma, heart
murmur, hepatitis, seizure, bleeding/anemia, injury]; Transfusions;
Anesthesia History.
PSH: Surgical history.
Current Medications: List all, including vitamins, herbs, etc.
Allergies: Define reaction type for each allergy.
Obstetrical History: Include dates, type of delivery, hours in labor,
birth weights, complications, etc.
Gynecologic History: Include age of menarche, length of menses
and frequency of cycle, lightness/heaviness of bleeding [e.g.,
13/3-5/reg/28-30], STDs, contraception, abnormal pap smears.
Family Hx: Include HTN, DM, birth defects, twin gestations,
pregnancy complications, breast cancer, ovarian cancer, etc.
Social Hx: Tobacco/EtOH/Illicit drugs. Include marital status,
number of children in home, support system, domestic violence
screening, etc.
Prenatal Labs/Studies: Heme: Hgb, Hct, ABO group, Rh, Antibody
status; ID: rubella, VDRL, GC, herpes, HIV, Hep B, Hep C;
16
17
Intrapartum
Intrapartum Progress Note. This type of documentation is used
frequently while a woman is in labor. Notes are typically written
every two hours. It is best to take the initiative yourself and be
present when checks are to occur.
Subjective: Complaints, tolerance, etc.
Objective: Vital signs, Labs, FHTs and pattern, Contractions
[intensity, duration, frequency], uterine resting tone (soft, firm,
tense), Cervix [dilation, effacement, position, station]
Assessment: (relate to labor curve, fetal distress, maternal
compromise)
Plan: (Intervention or lack of and persons involved in decision
making)
Delivery
Delivery Note. The following is template often used following
delivery.
Patient is a ___ y/o female G___ P___ Ab___ EDC___ who
presents c/o ______. Patient [describe labor, admission findings,
initial cervical exam] was admitted in _______ [active labor, etc.].
Patient required _______ (if anything). Fetal heart tones were
_______ throughout labor. Patient monitored __________ [external,
internal, etc.]. Patient was completely dilated at [time]. Patient went
on to deliver at [time] in _______ presentation a [male or female]
infant. Apgars were ___ at one minute and ____ at five minutes.
Weight was ____ lb _____ oz. Infant required ___________
[routine, etc.] resuscitation and was taken to _______ [NBN, NICU,
kept at bedside]. Cord had __ vessels and appeared ________
[normal, etc.]. Placental delivered an ______ [time] by _______
[spontaneous, manual, etc.]. Vagina and cervix examined and were
________ [report findings]. A ____ degree episiotomy was
performed to aid in delivery and was repaired in the usual fashion
with ______ suture. Repeat pelvic and rectal examination were
______ [normal, etc.] EBL ___.
18
Postpartum
When assessing a routine postpartum patient, the following areas
should be addressed:
General: Is the patient eating and tolerating her diet without
nausea or vomiting? Is she urinating, and if she has had a cesarean,
has she passed gas or had a bowel movement?
Pain: Does the patient have appropriate abdominal pain?
Contraction-like uterine pain may be merely after-pains, but a tender
fundus may be a sign of endometritis. Incision pain is common and
usually appropriate, but look for signs of infection.
Leg pain is common after birth due to the positioning of the
patient during labor, but calf tenderness can be a sign of thrombophlebitis or DVT. Encourage walking.
19
Discharge
Patients who have had vaginal delivery may be discharged 24
hours afterwards; this typically means on the first or second
postpartum day. Patients who have had cesarean delivery typically
stay at least 48 hours, which usually means the second or third
postoperative day. Obviously day of discharge depends on the time of
day delivery occurred. Infants whose mother was GBS positive are
required to stay 48 hours and for convenience the mothers also
usually stay the 48 hours as well.
Discharge Medications: PNV may be continued until the patient
runs out merely as a nutritional supplement regardless of whether she
21
Triage
For all triage patients, assess for FM, VB, LOF, contractions, and
other pertinent information based on complaints. Review prenatal
records and dating for pregnancy. All triage patients should have
EFM.
23
Patient Calls
Labor: For preterm patients with contractions, recommend
hydration and bed rest. If regular, short-interval pattern persists after
one hour, or if they have experienced a change in vaginal discharge
or vaginal bleeding, then the patient should be evaluated in triage.
For term multiparas patients with contractions q8-10 minutes for 1
hour, they should report to triage. Term nulliparas patients with
contractions q4-5 minutes for 2 hours should report to triage.
R O M : If history is plausible, patient should report to triage
regardless of gestational age.
Decreased Fetal Movement. Patients should be advised to do
kick counts. Patients should lie down and count fetal movements
for two hours or until 10 movements are appreciated, whichever is
first. If patient does not have 10 movements in two hours, they should
report to triage. At term, movements may be more subtle.
Headache: Headaches could be a sign of a hypertensive disorder,
and patients should be questioned for other related signs or
symptoms. Patients can take Tylenol, Regular or Extra Strength,
every four hours. Patients can also lie down and relax with a cold or
hot cloth on their heads. Patients whose headaches go unrelieved by
25
OB Clinic
The following is a guide for routine antenatal clinic care:
Before 28 wks gestation, patients are seen every 4 weeks.
Between 28-36 wks gestation, patients are seen every 2 weeks.
After 36 weeks, patients are seen weekly.
At each visit, check patients weight gain, urine, blood pressure.
Ask about VB, LOF, ctx, vag. discharge, dysuria, N/V, PNV use.
After 16-17 weeks, ask about FM. After 10-12 weeks gestation,
check FHT with Doppler. Between 20-36 weeks, measure fundal
height. Other questions are directed based upon patients past medical
history or complications of the pregnancy.
Initial Visit: Prenatal Labs: CBC, Type and Screen, Antibody
Screen, Rubella, RPR (VDRL), HbsAg, HCV, HIV, Pap,
GC/Chlamydia. If patients are unsure of their LMP, or if they have
a history of irregular menses, then offer a dating US.
16-18 Weeks: Quad Screen (AFP, Estriol, free B-HCG, Inhibin).
Offer Amniocentesis for AMA or family history of genetic disease.
16-20 Weeks: Ultrasound (Anatomy Scan).
26-28 Weeks: 1 hour glucose screen (50g). Rhogam injection if
mother Rh negative. Sign tubal papers if patient desires BTL.
35-36 Weeks: GBS culture.
27
28
29
30
31
OB pearls
The following are OB pearls. This information is fair game for
pimping by residents and attendings. Most of this information will
also be fair game for the end of rotation USMLE shelf exam.
Labor
Stages of Labor.
Stage
Event
Duration
First (Latent)
Dilation to 4 cm
6-11 h
First (Active)
4 cm -> 10 cm
4-6 h
Second
Delivery of baby
1-2 h
Third
Delivery of placenta
30 min
Should take about 1/2 the time for a multiparous woman.
Nulliparous
> 20 hr
> 12 hr
> 50 min
32
Multiparous
> 14 hr
> 6 hr
> 20 min
Intrapartum Monitoring
Fetal Heart Rate (FHR) strips should be assessed for their
baseline, variability, accelerations, and decelerations. Monitoring
may be conducted externally or internally with a fetal scalp electrode
(FSE).
The Baseline is the mean FHR within 5 beats/min. Less than 100
beats/min is bradycardia; greater than 160 beats/min is tachycardia.
Variability is quantified with four terms: absent variability
defines an undetectable range of amplitude; minimal variability
defines a detectable amplitude range less than or equal to 5
beats/min; moderate variability defines a amplitude range between
6 and 25 beats/min; and marked variability defines amplitude range
greater than 25 beats/min.
Accelerations are reassuring. A reactive strip is defined be the
presence of at least two accelerations 15 beats/min which last 15
seconds within a 20 minute period. A prolonged acceleration lasts
between 2 and 10 minutes, and a baseline change is said to occur if
an acceleration lasts longer than 10 minutes. Before 32 weeks
gestation, accelerations are defined as 10 beats/min which last 10
seconds.
Decelerations are categorized as early, late, and variable (both
mild and severe). Early decelerations are caused by fetal head
compression and generally mirror the onset and duration of the
contraction. Late decelerations are caused by uteroplacental
insufficiency and are often stimulated by uterine contractions,
beginning at or after the peak of the contraction. Intervention for late
decelerations include decreasing uterine contractions, left, lateral
decubitus position, administering oxygen, hydrating, and preparing
for immediate delivery if not resolving.
33
34
Gestational Diabetes
White Classification of Diabetes Mellitus
Class
A1
A2
B
C
D
F
H
R
T
Description
DM diagnosed during pregnancy which is diet controlled.
DM diagnosed during pregnancy requiring insulin.
Insulin-requiring DM diagnosed before pregnancy, after the age of 20,
lasing less than 10 years.
Insulin-requiring, onset at age 10-19, with duration 10-19 years.
Onset before age 10 or duration longer than 20 years, or associated with
CHTN or background retinopathy.
DM with renal disease.
DM with CAD.
DM with proliferative retinopathy.
DM with renal transplant.
IUGR
Commonly defined as growth at <10%tile, but significant morbidity
and mortality is noted when growth is <3%tile. One has to
distinguish between constitutionally small fetuses and those that are
truly growth restricted. Management includes modified bed rest,
growth US every 3 to 4 wks, fetal artery Doppler measurements (GA
< 35 wks), twice weekly antenatal testing, and steroids and early
delivery when indicated.
Note: The diagnosis of small for gestational age (SGA) can only be
made after the infant is born.
37
Rh Isoimmunization
Rh negative mothers may develop antigen to Rh if their fetus is
Rh positive. Since these antibodies are IgG, they can cross the
placenta and cause hemolytic disease of the fetus. To avoid this, Rh
negative mothers receive 300 mcg of RhoGAM (D Immunoglobulin)
at 28 weeks gestation, or if any situation where fetal and maternal
blood may be mixed, including abortion, amniocentesis, ectopic
pregnancy, or trauma. Mothers are also tested for Antibody D during
pregnancy. The D antibody is associated with Rh. If the mother is
antibody D positive, it shows some prior sensitization (in previous
pregnancies or possible in blood transfusions).
At birth, obtain cord blood of Rh negative mothers at delivery to
determine blood type of baby. If baby is Rh negative, RhoGAM
should not be necessary. If it is positive, RhoGAM is administered
again. High risk scenarios for isoimmunization include placenta
previa, abruptio placentae, cesarean section, and trauma. You may
perform a Kleihauer-Betke test to determine degree of blood transfer
and dose RhoGAM accordingly. If the mother at any time is positive
for the antibody, then it is necessary to know the babys Rh status. If
paternity is certain, then this can be done by checking the fathers
status. If paternity is unknown or if the father is Rh negative, then
maternal antibody titers are necessary (critical value is greater than
1:16) and perhaps serial amniocenteses for O D450 analyses and
stratification on the Liley Curve to direct treatment. Ultrasound
examination of MCA flows can also be correlated to degree of fetal
anemia.
Other non-ABO, non-Rh blood groups are associated with
hemolytic disease of the newborn, including Kell, Duffy, Kidd, and
MNS. Lewis antibodies are not associated with hemolytic disease.
Remember: Kell kills and Lewis lives (Lewis is IgM and therefore
does not cross the placenta).
38
Antepartum Monitoring
Antepartum fetal surveillance may be conducted by a Nonstress
Test (NST), fetal movement assessment or kick counts, Oxytocin
Challenge Test (OCT), and the Biophysical Profile (BPP).
An N S T is electronic fetal monitoring of FHR looking for
reactivity, as defined above. Kick counts are done by have the
patient lay on her side and counting fetal movements. At least ten
movements within two hours is reassuring. Vibroacoustic
stimulation to awaken the fetus or ingestion of food or caffeine can
often speed the success of these two tests.
An OCT is done by infusing oxytocin IV, titrated to cause three
contractions within ten minutes. A positive test is characterized by
the presence of at late decelerations following a contraction at least
half of the time.
A BPP is an ultrasound evaluation of the fetus which awards two
points each for fetal movement, fetal tone, fetal breathing, and an AFI
> 5 cm for a total of 8 points (10 points including a NST).
Antepartum fetal surveillance is indicated for the following:
39
3
5+
80+%
+1/+2
Induction of Labor
Indications
Preeclampsia/eclampsia
or +FHT
PROM
39 wks
Chorioamnionitis
39 wks
Post-term pregnancy
Fetal compromise
Intrauterine fetal death
Contraindications
Placenta previa
Fetal Maturity
36 wks since +serum Hcg
g.a.=gestational age
Preterm Terms.
Preterm labor: regular uterine contractions with progressive
cervical change or regular uterine contractions with a cervix that is at
least 2 cm dilated and 80% effaced at less than 37 weeks gestation
PROM: premature rupture of membranes, rupture of membranes
before the onset of labor
PPROM: preterm premature rupture of membranes, rupture of
membranes before 37 weeks gestation
Prolonged ROM: rupture of membranes for >24 hours before
delivery. Increases risk of chorioamnionitits and postpartum
endometritis
40
Sign
A Activity (Muscle Tone)
0 Points
1 Point
2 Points
Activity (Limp) Arms and Legs
Active Movement
Flexed
P Heart Rate
Absent
Below 100 bpm
Above 100 bpm
G Grimace (Reflex Irritability) No Response Grimace (cries,
Sneeze, cough,
some movement) pulls away
A Appearance (Skin Color) Blue-gray,
Pink body, blue
Normal over
pale all over hands and feet
entire body
R Respiration
Absent
Slow, irregular
Good, crying
A score of 7-10 is considered normal, while 4-7 might require some
resuscitative measures, and a baby with Apgars of 3 and below requires
immediate resuscitation.
41
Postpartum Hemorrhage
Blood loss greater than 500 mL following a vaginal delivery or
1000 mL follow a cesarean delivery is defined as a postpartum
hemorrhage, though we are notoriously inaccurate in our estimate of
actual blood loss. Nevertheless, a postpartum hemorrhage can lead to
significant maternal morbidity and mortality. There is a long list of
risk factors for postpartum hemorrhage including prior history of
hemorrhage, history of bleeding disorders, prolonged labor, the use of
Oxytocin in labor, multiple gestations, etc. When it happens, the
following differential diagnosis may be of value:
Uterine atony
Vaginal/cervical lacerations (esp. for operative deliveries)
Retained products of conception
Uterine inversion
Bleeding disorder
DIC (or consumptive coagulopathy)
Steps that must be taken prior to calling the attending include,
thorough pelvic exam for lacerations, uterine massage, the
administration of the appropriate uterotonics, and, esp. make sure that
there is adequate vascular access (ie. two large bore IV sites) with
fluid running and that initial blood work has been ordered (CBC, type
and screen, and coags if necessary).
When conservative medical management fails to bring the
hemorrhage under control, consideration of operative interventions
will be necessary. These include D&C, uterine artery embolization,
and exploratory laparotomy.
42
Gynecology
The Complete Gynecological History
Chief Complaint (CC):
History of Present Illness (HPI):
Past Medical History (PMH):
Past Surgical History (PSH):
Current Medications (Meds):
Allergies (All):
Family History (FH):
Social History (SH):
Gynecological History:
Menstrual History. Record the age at menarche, the duration of
menstrual flow (normal is 3-7 days), the interval of their cycle,
and a qualification of the amount of flow, such as heavy, light,
or normal.
Last Menstrual Period (LMP). The date of the first day of
bleeding of the last period and normality or abnormality of her
menses. The following terms are used to describe the menses:
Dysmenorrhea: painful menstrual flow.
Hypomenorrhea: decreased menstrual flow.
Intermenstrual bleed: bleeding between regular intervals.
Menometrorrhagia: Frequent, irregular, and excessive menstrual
flow.
Menorrhagia: Excessive menstrual flow both in duration and
amount.
Metrorrhagia: irregular bleeding.
Amenorrhea: absence of menses.
Oligomenorrhea: Irregular bleeds, >45 day interval.
Polymenorrhea: Frequent regular menstrual flow, <18 day cycle.
Menstrual cycle: 28+/- 7 days, with duration 5+/-2 days.
43
46
47
Gynecology Clinic
New Patients. For any new patient or an old patient who has not
been seen in 3 years or more, the following template can be used:
48
HPI: Age GP with LMP date presents for indication for visit, referred
by who (if applicable). Expand in any pertinent issues regarding
onset, duration, frequency, etc.
OB/GYN Hx: Gs + Ps and described each pregnancy (e.g., G1 1998
SVD at term without complications 8#3oz, G2 2000 SAb at 8wks, no
D&C, G3 2001 C/S at 35 wks for preeclampsia 5#1oz, G4 2003
ectopic at 4 wks with left salpingostomy).
MI (menstrual index): Menarche/frequency/duration and when
changed (if applicable). Any contraceptives and duration of use
(e.g., total OCP for 5 years, none currently, BTL, etc.). Any infertility
drugs used with dates and durations.
H/o STDs, PID: list which, date(s), treatment(s)
Sexual activity: Age of first intercourse, number of lifetime partners
H/o sexual abuse or assault
Pap hx: last pap and result, h/o any abnormal pap smears and if so
what treatment was offered
MMG hx: last mammogram date and result, any abnormals and
what treatments
Dexa scan hx: Any scans with date and result
Gyn surg hx: Any gyn surgeries and for what indication (i.e., dx lap
for pelvic pain, TAH for fibroids, Burch for SUI, D&C for
menorrhagia, etc.).
Urinary or fecal incontinence
PMH, PSH, SH, Meds, Allergies, ROS
FH: Usual medical problems + Breast CA, Colon CA, Gyn Ca if
yes, note family member on maternal/paternal side, and age/decade
of diagnosis if known.
Vitals/Exam as indicated.
Assessment: Age G P with diagnoses
Plan: Include when to return for follow-up
49
HPI: Age GP with LMP date presents for indication for visit. She was
last seen on date. Give pertinent information regarding whether the
patient is taking medicine as previously prescribed and outcomes,
changes to menstrual cycle since last visit, how long pt used
treatments and whether she is still using them, whether she saw
consultants and outcomes, etc.
Note and changes to PMH, PSH, FH since last visit if none, write
no changes. Allergies, Meds, ROS as usual.
Labs/Studies: Document date and results of each since last visit
(e.g., ultrasound results, pap results, Colpo, MMG, Dexa Scan,
EMB, etc.)
Vitals/Exam as indicated.
Assessment: Age G P with diagnoses
Plan: Include when to return for follow-up
50
51
Gynecologic-Oncology
Gyn-Onc Sample H&P
Date __________ Time _________
CC: swollen L leg
HPI: Ms. Jones is a 69 yo POD#7 from a TAH/BSO, PPLND for
Stage IC, grade 3 endometrial cancer. She presented to the office
today with a complaint of increased swelling of the LLE, pain, and
redness. Venous dopplers reveal a thrombus in the L common
femoral vein. She is being admitted for anti-coagulation. Denies
SOB or CP.
Meds: Vasotec 5 mg po daily, Percocet 5/325, 1 po q6 hours prn.
All: Sulfa (rash)
PMH: HTN, NIDDM
PSH: POD#7 s/p TAH/BSO, PPLND; Appendectomy (2/89);
Cholecystectomy (5/94).
Obstetrical History: G2P2002, with 2 NSVDs at term.
Gynecologic History: Spontaneous menopause at age 47, no
ERT, last mammogram 1/04, normal.
Family Hx: CAD in M; Prostate cancer in F; No hx of breast, colon
or gyn malignancies.
Social Hx: Denies tobacco/EtOH/Illicit drugs. Widowed, lives with
daughter in Erwin.
ROS: Skin: neg. HEENT: neg. CV: no CP, no orthopnea. Resp: no
SOB. GI: no N/V, no constipation, diarrhea, melena. GU: slight
vaginal d/c, no odor. Neuro: neg. Endocrine: neg. Constitutional:
fatigue. Hem/lymph: neg.
PE: VS: T-99.1 P-89 R-22 BP 107/74, Gen: well-appearing elderly
female in NAD. HEENT: NCAT, neck FROM, supple, sclerae
clear, pharynx clear. CV-RRR, no M/R/G. Resp: CTA-B.
Labs: Pending. LE Dopplers: thrombus in L common femoral vein.
Assessment:
Plan:
52
Cancer Staging
Cervical Cancer Staging (FIGO System)
Stage 0 Carcinoma in situ (CIS); CIN III. Also called pre-malignant
or precancerous.
Stage I Cancer in the cervix only
Ia Invasion of the cervical tissues can only be seen with a
microscope.
Ia1 Stromal invasion not more than 3.0 mm and extension
not more than 7.0 mm.
Ia2 Stromal invasion more than 3.0 mm but not more than
5.0 mm and extension not more than 7.0 mm.
Ib Lesions wider than 7 mm or deeper than 5 mm, or that can be
seen without a microscope.
Ib1 Lesions less than 4.0 cm.
Ib2 Lesions more than 4.0 cm,
Stage II Cancer extends beyond the cervix, but not as far as the
pelvic wall or the lower third of the vagina.
IIa Extends to upper part of the vagina, but not to the surrounding
tissues (parametria).
IIb Extends to the parametrial tissues (but not to the pelvic wall).
Stage III The cancer has extended to the lower third of the vagina or
to the pelvic wall.
IIIa The cancer has spread to the lower third of the vagina, but
nowhere else.
IIIb The cancer has spread to the pelvic wall or caused
hydronephrosis.
Stage IV Cancer has spread to the bladder, rectum, or outside the
pelvis.
IVa Spread to the rectum or bladder.
IVb Metastasis to distant organs such as the lungs or liver.
53
IIb Tumor has spread to other parts of the pelvis, but no cancer
cells are found in ascites or peritoneal washings.
IIc Stage IIa or IIb, but tumor is either visible on the outside of
the ovary or the capsule has burst or there is ascites with
malignant cells or positive peritoneal washings.
Stage III Tumor is found on the surfaces of abdominal organs and/or
in nearby lymph nodes.
IIIa Microscopic seeding of abdominal peritoneal surfaces.
IIIb Abdominal implants smaller than 2 cm.
IIIc Abdominal implants larger than 2 cm and/or positive
retroperitoneal or inguinal nodes.
Stage IV Distant metastases; pleural effusion with positive cytology;
parenchymal liver metastasis.
Vaginal Cancer Staging (FIGO System)
Stage 0 Carcinoma in situ, VAIN 3, severe vaginal dysplasia. This
stage is not malignant.
Stage I Cancer is limited to the wall of the vagina.
Stage II Cancer has extended through the vaginal wall, into the
parametrium, but not as far as the wall of the pelvis.
Stage III Cancer has extended to the pelvic wall and/or to the local
lymph nodes.
Stage IV Cancer has invaded the bladder or rectum and/or spread
outside the pelvis.
IVa Tumor has spread to the inside of the bladder or rectum.
IVb Tumor has spread outside the pelvic area.
Vulvar Cancer Staging (FIGO System)
Stage 0 Carcinoma in situ, VIN 3, severe vulvar dysplasia. This stage
is not malignant.
Stage I Confined to vulva or perineum, tumor 2 cm or less.
Ia Less than 1 mm of stromal invasion.
Ib More than 1 mm of stromal invasion.
55
57
58
59
60
61
62
Abortion
Amniotic Fluid Embolism
Amniotic Fluid Index
Alpha-feto protein
Artificial Rupture of
Membranes
ASCUS Atypical Squamous Cells of
Undetermined Significance
AUB
Abnormal Uterine Bleeding
BPD
BPP
BSO
BTL
Bx
CCM
C/D/I
CIN
DIC
Biparietal Diameter
Biophysical Profile
Bilateral SalpingoOopherectomy
Bilateral Tubal Ligation
Biopsy
CKC
CMT
CPD
CST
CS
CTA
CTX
CVA
CVS
Cx
D&C
D&E
DES
DTR
DUB
Dx
Disseminated Intravascular
Coagulopathy
Deep Tendon Reflex
Dysfunctional Uterine Bleeding
Diagnosis
E2
EDC
EDD
EFM
EFW
EGA
ETOH
Estradiol
Estimated Date of Confinement
Estimated Date of Delivery
Electronic Fetal Monitoring
Estimated Fetal Weight
Estimated Gestational Age
Alcohol
FBS
Fasting Blood Sugar
FF@/U Fundus Firm At/Below
Umbilicus
fFN
Fetal Fibronectin
FH
Fundal Height
FHR
Fetal Heart Rate
FHT
Fetal Heart Tones
FL
Femur Length
FLM
Fetal Lung Maturity
FM
Fetal Movement
FOB
Father of Baby
FSE
Fetal Scalp Electrode
FSH
Follicle Stimulating Hormone
Ft
Fingertip
FTP
Failure to Progress
G
GBS
GDM
GIFT
63
Gravida
Group Beta Strep
Gestational Diabetes Mellitus
Gamete Intra-Fallopian
Transfer
GnRH
GTT
Gonadotropin Releasing
Hormone
Glucose Tolerance Test
hCG
Human Chorionic
Gonadotropin
HELLP Hemolysis, Elevated Liver
Enzymes, Low Platelets
HGSIL High Grade Squamous
Intraepithelial Lesion
HRT
Hormone Replacement
Therapy
HSG
Husterosalpingogram
HTN
Hypertension
IUD
IUGR
IUFD
IUI
IUP
IUPC
Intrauterine Device
Intrauterine Growth Restriction
Intrauterine Fetal Demise
Intrauterine Insemination
Intrauterine Pregnancy
Intrauterine Pressure Catheter
KB
Kleihauer-Betke
L&D
LAVH
LBW
LCTS
LEEP
LGA
LH
LMP
LND
LOA
LOF
L/S
LTCS
Lecithin/Sphingomyelin Ratio
Low Transverse Cesarean
Section
M/F
MIFT
Maternal/Fetal
Micro-injection Fallopian
Transfer
Midline Episiotomy
MLE
NICU
NST
NSVD
OCP
OCT
OOB
P
PCOS
PE
PID
PIH
Para
Polycystic Ovary Syndrome
Pulmonary Embolism
Pelvic Inflammatory Disease
Pregnancy Induced
Hypertension
PNV
Prenatal Vitamins
POC
Products of Conception
POD
Postoperative Day
PP
Postpartum
PPD
Postpartum Day
PPP
Pitocin Per Protocol
PRBC Packed Red Blood Cells
PROM Premature Rupture of
Membranes
PPROM Preterm Premature Rupture of
Membranes
PPPROM Prolonged Preterm
Premature Rupture of
Membranes
64
PSTT
PTL
RI
R LTCS
ROM
RRR
Rubella Immune
Repeat LTCS
Rupture of Membranes
Regular Rate and Rhythm
SAb
SDE
Spontaneous Abortion
Suction, Dilatation, and
Evacuation
SGA
Small for Gestational Age
SROM Spontaneous Rupture of
Membranes
SSE
Sterile Speculum Exam
STD
Sexually Transmitted Disease
SUI
Stress Urinary Incontinence
SVE
Sterile Vaginal Exam
TAH
Total Abdominal Hysterectomy
TOA
Tubo-Ovarian Abscess
TORCH Toxoplasmosis, Other, Rubella,
Cytomegalovirus, Herpes
TUFT Trans-uterine Fallopian
Transfer
TVH
Total Vaginal Hysterectomy
TVT
Transvaginal Tape
UC
US
Uterine Contractions
Ultrasound
VBAC
65
WNL
ZIFT
Recommended Resources
Beckman, Charles R.B. et al. Obstetrics and Gynecology, 4 th Edition.
Lippincott, Williams & Wilkins, 2002.
Beck, William W. NMS Obstetrics and Gynecology, 4 th Edition.
Williams & Wilkins, 1997.
Gabbe, Steven G. et al. Obstetrics: Normal and Problem
Pregnancies, 4th Edition. Churchill Livingston, 2002.
Sakala, Elmar P. High-Yield Obstetrics and Gynecology. Lippincott,
Williams & Wilkins, 2001.
Evans, Mark et al. Obstetrics and Gynecology: PreTest SelfAssessment and Review. 9th Edition. Appleton and Lange, 2000.
Important Topics
Normal physiology of pregnancy
Prenatal care
Normal and abnormal labor
First and third trimester bleeding
Ectopic pregnancy
Preterm labor and delivery
Postpartum hemorrhage and other postpartum complications
IUGR (intrauterine growth retardation)
Pelvic inflammatory disease and STDs
Common vaginal infections
Methods of contraception
Endometriosis
Amenorrhea
Premenstrual syndrome
Abnormal uterine/vaginal bleeding
Menopause, hormone replacement therapy
Primary dysmenorrhea
66
Additional Notes
67
68